An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSMSybil Hosek, Brandy Rutledge, Nancy Liu et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 278
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy AdultsFrances Priddy, Deborah D. Brown, James G. Kublin et al.|Clinical Infectious Diseases|2008Cited by 246
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United StatesSybil Hosek, Craig M. Wilson, Raphael J. Landovitz et al.|JAMA Pediatrics|2017Cited by 226
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)Gavin Churchyard, Cecilia Morgan, Elizabeth M. Adams et al.|PLoS ONE|2011Cited by 137